Bioequivalence Study of Dr.Reddys Laboratories Limited, Glimepiride 1 mg Tablets in Healthy Subjects Under Fed Condition
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this bioequivalence study is to compare a test Glimepiride 1 mg tablets of
Dr.Reddy's Laboratories Limited versus reference Amaryl 1 mg tablets of Aventis
Pharmaceuticals Inc in healthy subjects, under fed condition.